Log In
Thursday 22nd March 2018

Plan to axe drug price fixing

21st April 2008

The government's intention to get rid of the Pharmaceutical Price Regulation Scheme (PPRS) would dramatically affect the healthcare communications industry, according to a prominent PR consultant.

Fleishman-Hillard director Claire Ashbridge-Thomlinson spoke at her agency's yearly healthcare industry debate. Ashbridge-Thomlinson  said: 'Fixed pricing will have implications for marketing spend and a huge impact on the PR and PA side. If pharma companies receive less money for their drugs in the UK, they will have less to spend on comms activity. PR and PA agencies need to be aware of this."

Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Article Information

Title: Plan to axe drug price fixing
Author: Jess Laurence
Article Id: 6438
Date Added: 21st Apr 2008


PR Week

Recent Related Articles

Prescription drug addiction to be reviewed

Contingency plans for trusts after Carillion collapse


Add to scrapbook
Show Comments
Add comment
Find all related articles


Mayden - Innovative cloud-based applications for healthcare
© Mayden Foundation 2018